Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab ; volume:6 ; number:1 ; day:17 ; month:10 ; year:2018 ; pages:1-8 ; date:12.2018
Journal for ImmunoTherapy of Cancer ; 6, Heft 1 (17.10.2018), 1-8, 12.2018
- Creator
-
Zahoor, Haris
- Contributor
-
Barata, Pedro C.
Jia, Xuefei
Martin, Allison
Allman, Kimberly D.
Wood, Laura S.
Gilligan, Timothy D.
Grivas, Petros
Ornstein, Moshe C.
Garcia, Jorge A.
Rini, Brian I.
SpringerLink (Online service)
- DOI
-
10.1186/s40425-018-0425-8
- URN
-
urn:nbn:de:101:1-2018112513530041233575
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zahoor, Haris
- Barata, Pedro C.
- Jia, Xuefei
- Martin, Allison
- Allman, Kimberly D.
- Wood, Laura S.
- Gilligan, Timothy D.
- Grivas, Petros
- Ornstein, Moshe C.
- Garcia, Jorge A.
- Rini, Brian I.
- SpringerLink (Online service)
Other Objects (12)
Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report